4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002676
Options or other derivatives
- Chief Technology Officer acquired 526,020 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +429,984 | 429,984 | D | ||
| Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +96,036 | 96,036 | D | ||
Loading xslF345X03/a4.xml…